EGFR and bladder transitional cell carcinoma: These mechanisms conceptually align with features of consensus molecular subtypes—e.g., EGFR/MAPK activity described in Basal/Squamous and FGFR3-centered signaling in Luminal Papillary tumors—providing a biologic bridge for interpreting Pb-related signals in BLCA [16].